Intermediate-Timed Alemtuzumab May Be Associated With Increased Graft Rejection in Reduced-Intensity Bone Marrow Transplant for Sickle Cell Disease

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.391
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Unrelated Donor Hematopoietic Stem Cell Transplantation for the Treatment of Non-Malignant Genetic Diseases: An Alemtuzumab Based Regimen Is Associated With Cure of Clinical Disease; Earlier Clearance of Alemtuzumab May Be Associated With Graft Rejection

American Journal of Hematology
Hematology
2015English

Host vs. Graft Mismatches May Impact on Rejection of Haploidentical Bone Marrow Transplants in Thalassemia Patients Using Post-Transplant Cyclophosphamide

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Increased Intensity of Acute Graft-Versus-Host Disease After Reduced-Intensity Bone Marrow Transplantation Compared to Conventional Transplantation From an HLA-matched Sibling in Children

Bone Marrow Transplantation
TransplantationHematology
2006English

P.054 Bone Marrow Transplant Restores Cerebrovascular Reactivity (CVR) in Sickle Cell Disease (SCD): A Case Presentation

Canadian Journal of Neurological Sciences
MedicineNeurology
2017English

Haploidentical Bone Marrow Transplantation Improves Cerebral Hemodynamics in Adults With Sickle Cell Disease

American Journal of Hematology
Hematology
2019English

Quantitative MRI Analysis of Craniofacial Bone Marrow in Patients With Sickle Cell Disease

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2012English

Reduced Toxicity, Myeloablative Conditioning With BU, Fludarabine, Alemtuzumab and SCT From Sibling Donors in Children With Sickle Cell Disease

Bone Marrow Transplantation
TransplantationHematology
2014English

Impaired Effector Memory T-Cell Regulation Facilitates Graft Versus Host Disease in CCR7-Deficient Bone Marrow Transplant Chimeras

Transplantation
Transplantation
2009English

Macrophage Activation Syndrome and Post-Transplant Microangiopathy Following Haploidentical Bone Marrow Transplantation for Sickle Cell Anemia

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy